G290-1069 Screening compound: 4-[5-oxopyrido[2,3-b][1,5]benzothiazepin-6(5H)-yl]-N~1~-(2-pyridylmethyl)butanamide

G290-1069 Screening compound: 4-[5-oxopyrido[2,3-b][1,5]benzothiazepin-6(5H)-yl]-N~1~-(2-pyridylmethyl)butanamide
G290-1069 Screening compound: 4-[5-oxopyrido[2,3-b][1,5]benzothiazepin-6(5H)-yl]-N~1~-(2-pyridylmethyl)butanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G290-1069
4-[5-oxopyrido[2,3-b][1,5]benzothiazepin-6(5H)-yl]-N~1~-(2-pyridylmethyl)butanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G290-1069

Molecular Formula

C22H20N4O2S (C22 H20 N4 O2 S)

Compound Name

4-[5-oxopyrido[2,3-b][1,5]benzothiazepin-6(5H)-yl]-N~1~-(2-pyridylmethyl)butanamide

IUPAC name

4-{9-oxo-2-thia-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaen-10-yl}-N-[(pyridin-2-yl)methyl]butanamide

SMILES

O=C(CCCN(c(cccc1)c1Sc1ncccc11)C1=O)NCc1ncccc1

InChI

InChI=1S/C22H20N4O2S/c27-20(25-15-16-7-3-4-12-23-16)11-6-14-26-18-9-1-2-10-19(18)29-21-17(22(26)28)8-5-13-24-21/h1-5,7-10,12-13H,6,11,14-15H2,(H,25,27)

InChI Key

OBDWILGGOIZHJA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14995300

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

404.49

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.299

Distribution Coefficient, logD

2.299

Water Solubility, LogSw

-2.87

Polar Surface Area

60.446

Acid Dissociation Constant (pKa)

12.81

Base Dissociation Constant (pKb)

4.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

G290-1069 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Cardiovascular Library (22201 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G290-1069 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G290-1069?
Check Price and Availability of G290-1069, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G290-1069 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G290-1069
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G290-1069
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G290-1069 available by request